Ocular Therapeutix
OCUL
OCUL
122 hedge funds and large institutions have $176M invested in Ocular Therapeutix in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 39 increasing their positions, 36 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
122
Holders Change
-9
Holders Change %
-6.87%
% of All Funds
2.06%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
16
Increased
39
Reduced
36
Closed
21
Calls
$446K
Puts
$180K
Net Calls
+$266K
Net Calls Change
+$378K
Top Buyers
| 1 |
MP
1
MSD Partners
New York
|
$4.09M |
| 2 |
2
Federated Hermes
Pittsburgh,
Pennsylvania
|
$4.79M |
| 3 |
BS
3
Banco Santander
Madrid,
Spain
|
$2.24M |
| 4 |
UOC
4
UBS O'Connor
Chicago,
Illinois
|
$2.06M |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$1.38M |
Top Sellers
| 1 |
1
Two Sigma Investments
New York
|
$0 |
| 2 |
2
Millennium Management
New York
|
$1.4M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$15.7M |
| 4 |
4
Two Sigma Advisers
New York
|
$1.56M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$5.68M |
